Form ABS-15G/A FEDERAL NATIONAL MORTGAG
http://archive.fast-edgar.com/20240513/AS22V222H22282R2222R2M42M3MWE2225262
Filed on: May 13, 2024
Form 4 KELLY SERVICES INC For: May 09 Filed by: Adolph Gerald S
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form ABS-15G/A FEDERAL NATIONAL MORTGAG
http://archive.fast-edgar.com/20240513/AS22V222H22282R2222R2M42M3MW42225262
Filed on: May 13, 2024
Form 6-K NOKIA CORP For: May 13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
Report on Form 6-K dated May 13, 2024
(Commission File No. 1-13202)
Nokia Corporation
Karakaari 7
FI-02610 Espoo
Finland
(Translation of the registrant’s name into English and address of registrant’s principal executive office)
... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B5 Summit Therapeutics Inc.
-
Form ABS-15G/A FEDERAL NATIONAL MORTGAG
-
Form ABS-15G/A FEDERAL NATIONAL MORTGAG
-
Form 8-K Verrica Pharmaceuticals For: May 13
-
Form 13F-HR E Fund Management Co., For: Mar 31
-
Form 6-K Freightos Ltd For: May 13
-
Form ABS-15G/A FEDERAL NATIONAL MORTGAG
-
Form D/A Anavio Equity Capital
-
Form 8-K Abacus Life, Inc. For: May 13
-
Form ABS-15G/A FEDERAL NATIONAL MORTGAG
-
Form 6-K Ferrari N.V. For: May 13
-
Form ABS-15G/A FEDERAL NATIONAL MORTGAG
-
Form DEFA14A CROWN CASTLE INC.
-
Form 6-K Steakholder Foods Ltd. For: May 13
-
Form D/A Kohinoor Core (Cayman)
-
Form 13F-HR HFR Wealth Management, For: Mar 31
-
Form ABS-15G FEDERAL NATIONAL MORTGAG
-
Form 10-Q NET Power Inc. For: Mar 31
-
Form DEFA14A CROWN CASTLE INC.
-
Form 6-K ELTEK LTD For: May 13
-
Form 8-K Akoustis Technologies, For: May 13
-
Form 8-K Milestone Pharmaceutical For: May 13
-
Form 20-F Ferroglobe PLC For: Dec 31
-
Form 10-Q Avalo Therapeutics, Inc. For: Mar 31
-
Form 8-K NET Power Inc. For: May 13
-
Form 10-Q RAND CAPITAL CORP For: Mar 31
-
Form 13F-HR Regal Partners Ltd For: Mar 31
-
Form 13F-HR Tredje AP-fonden For: Mar 31
-
Form 10-Q Quince Therapeutics, For: Mar 31
-
Form 10-Q Iterum Therapeutics plc For: Mar 31
-
Form 8-K Avalo Therapeutics, Inc. For: May 13
-
Form 10-Q Galera Therapeutics, For: Mar 31
-
Form 10-Q TScan Therapeutics, Inc. For: Mar 31
-
Form 8-K Moleculin Biotech, Inc. For: May 13
-
Form 6-K LITHIUM AMERICAS CORP. For: May 13
-
Form S-8 Apogee Therapeutics,
-
Form 13F-NT Viola Growth Management For: Mar 31
-
Form 8-K BOYD GAMING CORP For: May 09
-
Form 13F-NT Viola Ventures GP 3 Ltd. For: Mar 31
-
Form 8-K Autolus Therapeutics For: May 13
-
Form 8-K AVANOS MEDICAL, INC. For: May 13
-
Form 13F-HR Dunhill Financial, LLC For: Mar 31
-
Form 13F-HR Viola Ventures V.C. Mana For: Mar 31
-
Form SC TO-C INCYTE CORP Filed by: INCYTE CORP
-
Form 13F-HR Handelsbanken Fonder AB For: Mar 31
-
Form 6-K Gildan Activewear Inc. For: May 13
-
Form 8-K INCYTE CORP For: May 12
-
Form 10-Q Akoustis Technologies, For: Mar 31
-
Form 10-Q PRECISION BIOSCIENCES For: Mar 31
-
Form 10-Q Fulcrum Therapeutics, For: Mar 31
